Petco Health and Wellness (WOOF) Financials

Petco Health and Wellness logo
$2.52 +0.03 (+1.20%)
Closing price 04:00 PM Eastern
Extended Trading
$2.54 +0.02 (+0.79%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Petco Health and Wellness

Annual Income Statements for Petco Health and Wellness

This table shows Petco Health and Wellness' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-96 -26 164 91 -1,280 -102 9.07
Consolidated Net Income / (Loss)
-104 -32 160 90 -1,280 -102 9.07
Net Income / (Loss) Continuing Operations
-104 -32 160 90 -1,280 -102 9.07
Total Pre-Tax Income
-142 -42 202 112 -1,324 -128 -5.03
Total Operating Income
111 194 266 226 -1,180 7.05 120
Total Gross Profit
1,907 2,107 2,427 2,427 2,354 2,324 2,305
Total Revenue
4,435 4,920 5,807 6,036 6,255 6,116 5,961
Operating Revenue
4,435 4,920 5,807 6,036 6,255 6,116 5,961
Total Cost of Revenue
2,528 2,813 3,381 3,609 3,901 3,792 3,656
Operating Cost of Revenue
2,528 2,813 3,381 3,609 3,901 3,792 3,656
Total Operating Expenses
1,796 1,912 2,161 2,202 3,534 2,317 2,185
Selling, General & Admin Expense
1,777 1,912 2,161 2,202 2,312 2,317 2,185
Impairment Charge
19 0.00 0.00 0.00 1,223 0.00 0.00
Total Other Income / (Expense), net
-253 -236 -64 -113 -144 -135 -125
Interest Expense
253 237 98 102 152 144 132
Interest & Investment Income
0.34 0.65 0.06 1.03 3.41 3.71 6.31
Other Income / (Expense), net
0.00 0.00 34 -13 4.73 4.80 0.00
Income Tax Expense
-36 -3.34 53 35 -28 -7.48 6.27
Other Gains / (Losses), net
2.44 6.48 11 13 16 19 20
Net Income / (Loss) Attributable to Noncontrolling Interest
-8.11 -5.25 -4.61 -0.89 0.00 0.00 0.00
Basic Earnings per Share
($0.46) ($0.13) $0.62 $0.34 ($4.78) ($0.37) $0.03
Weighted Average Basic Shares Outstanding
208.93M 210.68M 264.26M 265.52M 267.55M 273.41M 279.56M
Diluted Earnings per Share
($0.46) ($0.13) $0.62 $0.34 ($4.78) ($0.37) $0.03
Weighted Average Diluted Shares Outstanding
208.93M 210.68M 265.34M 265.95M 267.55M 273.41M 286.15M
Weighted Average Basic & Diluted Shares Outstanding
- - 303.03M 304.55M 307.37M 315.13M 322.15M

Quarterly Income Statements for Petco Health and Wellness

This table shows Petco Health and Wellness' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 10/28/2023 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025 1/31/2026 5/2/2026
Net Income / (Loss) Attributable to Common Shareholders
-1,241 -23 -46 -25 -17 -14 -12 14 9.33 -2.58 -15
Consolidated Net Income / (Loss)
-1,241 -23 -46 -25 -17 -14 -12 14 9.33 -2.58 -15
Net Income / (Loss) Continuing Operations
-1,241 -23 -46 -25 -17 -14 -12 14 9.33 -2.58 -15
Total Pre-Tax Income
-1,268 -39 -56 -34 -22 -16 -16 11 -1.82 1.93 -19
Total Operating Income
-1,232 0.17 -17 2.47 3.98 17 16 43 29 32 25
Total Gross Profit
550 606 579 581 576 589 570 585 569 581 574
Total Revenue
1,494 1,674 1,529 1,524 1,511 1,552 1,493 1,489 1,464 1,515 1,497
Operating Revenue
1,494 1,674 1,529 1,524 1,511 1,552 1,493 1,489 1,464 1,515 1,497
Total Cost of Revenue
944 1,068 950 943 936 963 923 903 895 934 922
Operating Cost of Revenue
944 1,068 950 943 936 963 923 903 895 934 922
Total Operating Expenses
1,782 606 595 578 572 572 554 542 540 549 550
Selling, General & Admin Expense
560 606 595 578 572 572 554 542 540 549 550
Total Other Income / (Expense), net
-35 -42 -39 -36 -26 -39 -32 -32 -31 -30 -43
Interest Expense
37 40 37 37 36 34 33 33 33 32 45
Interest & Investment Income
1.14 -2.81 0.42 0.67 1.35 -3.61 1.36 0.91 1.81 2.22 1.50
Other Income / (Expense), net
0.11 - -2.67 0.00 8.47 -1.00 0.00 0.00 0.00 - 0.00
Income Tax Expense
-23 -10 -4.48 -4.65 -0.86 2.50 0.50 0.75 -6.28 11 2.20
Other Gains / (Losses), net
3.57 - 4.89 4.19 4.48 - 4.61 4.08 4.87 6.79 5.56
Basic Earnings per Share
($4.63) ($0.09) ($0.17) ($0.09) ($0.06) ($0.05) ($0.04) $0.05 $0.03 ($0.01) ($0.05)
Weighted Average Basic Shares Outstanding
267.85M 267.55M 269.77M 273.07M 274.50M 273.41M 277.55M 279.06M 280.38M 279.56M 283.68M
Diluted Earnings per Share
($4.63) ($0.09) ($0.17) ($0.09) ($0.06) ($0.05) ($0.04) $0.05 $0.03 ($0.01) ($0.05)
Weighted Average Diluted Shares Outstanding
267.85M 267.55M 269.77M 273.07M 274.50M 273.41M 277.55M 285.74M 288.22M 286.15M 283.68M
Weighted Average Basic & Diluted Shares Outstanding
306.28M 307.37M 310.78M 312.15M 313.45M 315.13M 316.78M 318.05M 319.03M 322.15M 323.36M

Annual Cash Flow Statements for Petco Health and Wellness

This table details how cash moves in and out of Petco Health and Wellness' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
Net Change in Cash & Equivalents
-32 -35 102 -8.16 -77 45 88
Net Cash From Operating Activities
110 269 358 346 216 178 314
Net Cash From Continuing Operating Activities
110 269 358 346 216 178 314
Net Income / (Loss) Continuing Operations
-104 -32 160 90 -1,280 -102 9.07
Consolidated Net Income / (Loss)
-104 -32 160 90 -1,280 -102 9.07
Depreciation Expense
174 175 172 194 204 209 197
Amortization Expense
23 24 5.80 4.94 4.97 4.90 5.02
Non-Cash Adjustments To Reconcile Net Income
483 481 458 485 1,713 438 424
Changes in Operating Assets and Liabilities, net
-465 -379 -438 -428 -426 -372 -321
Net Cash From Investing Activities
-139 -157 -237 -320 -207 -124 -125
Net Cash From Continuing Investing Activities
-139 -157 -237 -320 -207 -124 -125
Purchase of Property, Plant & Equipment
-157 -160 -239 -278 -226 -128 -127
Acquisitions
-3.26 0.00 -4.33 -45 -6.73 -0.63 0.00
Purchase of Investments
-0.59 -1.00 0.00 0.00 0.00 -0.46 0.00
Sale of Property, Plant & Equipment
0.00 3.30 0.23 2.34 0.00 1.37 2.54
Sale and/or Maturity of Investments
0.00 0.07 6.14 0.00 25 1.00 0.00
Other Investing Activities, net
21 0.00 0.00 0.00 0.00 2.81 0.00
Net Cash From Financing Activities
-3.07 -147 -19 -34 -85 -8.75 -102
Net Cash From Continuing Financing Activities
-3.07 -147 -19 -34 -85 -8.75 -102
Repayment of Debt
-1,293 -1,555 -1,716 -140 -348 -204 -95
Issuance of Debt
1,297 476 1,700 123 273 201 0.00
Issuance of Common Equity
0.24 936 0.00 0.00 0.00 2.50 0.00
Other Financing Activities, net
-7.01 -3.65 0.59 -17 -10 -8.23 -6.50
Cash Interest Paid
219 179 66 91 143 139 126

Quarterly Cash Flow Statements for Petco Health and Wellness

This table details how cash moves in and out of Petco Health and Wellness' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 10/28/2023 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025 1/31/2026 5/2/2026
Net Change in Cash & Equivalents
-34 -5.59 -46 43 -13 61 -43 51 60 20 -101
Net Cash From Operating Activities
34 47 -8.41 69 21 96 -15 86 90 154 -31
Net Cash From Continuing Operating Activities
34 47 -8.41 69 21 96 -15 86 90 154 -31
Net Income / (Loss) Continuing Operations
-1,241 -23 -46 -25 -17 -14 -12 14 9.33 -2.58 -15
Consolidated Net Income / (Loss)
-1,241 -23 -46 -25 -17 -14 -12 14 9.33 -2.58 -15
Depreciation Expense
51 52 50 50 50 50 50 49 50 48 49
Amortization Expense
1.21 1.31 1.22 1.22 1.23 1.24 1.25 1.25 1.26 1.26 1.34
Non-Cash Adjustments To Reconcile Net Income
1,343 123 121 114 103 109 107 107 106 104 119
Changes in Operating Assets and Liabilities, net
-119 -107 -134 -71 -117 -50 -162 -86 -76 2.70 -185
Net Cash From Investing Activities
-50 -51 -32 -26 -31 -34 -27 -31 -29 -37 -38
Net Cash From Continuing Investing Activities
-50 -51 -32 -26 -31 -34 -27 -31 -29 -37 -38
Purchase of Property, Plant & Equipment
-63 -49 -33 -27 -31 -37 -28 -32 -29 -37 -38
Acquisitions
-2.46 -2.23 -0.10 -0.16 -0.21 -0.17 0.00 - - - 0.00
Purchase of Investments
- - - - - - 0.00 - - - 0.00
Sale of Property, Plant & Equipment
- - 0.00 - 0.23 0.12 1.28 1.15 0.12 - 0.00
Sale and/or Maturity of Investments
15 - 1.00 - - - 0.00 - - - 0.00
Other Investing Activities, net
- - - - - 2.60 0.00 - - - 0.30
Net Cash From Financing Activities
-18 -1.31 -5.63 -0.27 -1.91 -0.95 -0.33 -3.95 -1.07 -96 -33
Net Cash From Continuing Financing Activities
-18 -1.31 -5.63 -0.27 -1.91 -0.95 -0.33 -3.95 -1.07 -96 -33
Repayment of Debt
-15 -273 -176 -28 - - 0.00 - - -95 -1,528
Issuance of Debt
- 273 173 28 - - 0.00 - - - 1,500
Issuance of Common Equity
- - 0.83 1.67 - - 0.00 -0.97 - - 0.00
Other Financing Activities, net
-3.27 -1.31 -3.50 -1.86 -1.91 -0.95 -0.33 -2.98 -1.07 -1.15 -4.20
Cash Interest Paid
35 36 34 35 36 34 31 31 32 31 21
Cash Income Taxes Paid
3.84 0.93 1.28 14 9.07 10 0.00 2.39 0.90 - 0.00

Annual Balance Sheets for Petco Health and Wellness

This table presents Petco Health and Wellness' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
Total Assets
6,076 5,473 6,613 5,363 5,194 5,173
Total Current Assets
778 1,071 1,016 952 974 1,020
Cash & Equivalents
111 212 202 125 166 257
Accounts Receivable
42 56 50 44 40 46
Inventories, net
539 675 652 685 653 590
Prepaid Expenses
40 42 51 59 54 52
Other Current Assets
46 86 61 39 61 75
Plant, Property, & Equipment, net
628 727 803 816 725 656
Plant, Property & Equipment, gross
- - - - - 2,378
Accumulated Depreciation
- - - - - 1,722
Total Noncurrent Assets
4,671 3,675 4,794 3,595 3,495 3,497
Goodwill
2,179 2,184 2,194 980 980 980
Intangible Assets
1,025 - 1,025 1,025 1,025 1,025
Other Noncurrent Operating Assets
1,466 1,491 1,575 1,590 1,490 1,492
Total Liabilities & Shareholders' Equity
6,076 6,498 6,613 5,363 5,194 5,173
Total Liabilities
4,020 4,242 4,231 4,179 4,081 4,009
Total Current Liabilities
875 1,053 1,021 1,113 1,139 1,134
Short-Term Debt
2.20 - 23 16 5.35 4.61
Accounts Payable
339 404 381 485 493 451
Accrued Expenses
146 211 218 200 177 205
Current Employee Benefit Liabilities
129 151 90 101 157 154
Other Current Liabilities
258 266 310 311 306 320
Total Noncurrent Liabilities
3,145 3,189 3,210 3,066 2,942 2,875
Long-Term Debt
1,646 1,640 1,628 1,576 1,578 1,489
Noncurrent Deferred & Payable Income Tax Liabilities
281 318 303 252 218 235
Other Noncurrent Operating Liabilities
1,218 1,230 1,279 1,238 1,146 1,152
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,055 2,256 2,381 1,184 1,114 1,164
Total Preferred & Common Equity
2,069 2,274 2,381 1,184 1,114 1,164
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
2,069 2,274 2,381 1,184 1,114 1,164
Common Stock
2,092 2,134 2,153 2,230 2,281 2,313
Retained Earnings
-22 142 233 -1,047 -1,149 -1,140
Accumulated Other Comprehensive Income / (Loss)
-1.28 -2.24 -4.10 1.82 -18 -8.39

Quarterly Balance Sheets for Petco Health and Wellness

This table presents Petco Health and Wellness' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 10/29/2022 4/29/2023 7/29/2023 10/28/2023 5/4/2024 8/3/2024 11/2/2024 5/3/2025 8/2/2025 11/1/2025 5/2/2026
Total Assets
6,577 6,572 6,662 5,427 5,259 5,277 5,211 5,121 5,153 5,205 5,085
Total Current Assets
1,019 977 1,025 1,008 904 942 932 920 940 1,007 961
Cash & Equivalents
149 149 173 140 90 128 117 133 189 237 167
Accounts Receivable
46 45 66 50 42 47 40 36 35 43 37
Inventories, net
723 668 675 730 681 672 690 645 609 618 633
Prepaid Expenses
44 53 55 47 65 60 47 67 60 44 64
Other Current Assets
57 61 55 41 26 35 38 39 47 65 60
Plant, Property, & Equipment, net
792 812 820 828 779 760 740 704 688 670 646
Plant, Property & Equipment, gross
1,938 2,042 2,090 2,143 2,177 2,207 2,234 2,285 2,312 2,343 2,404
Accumulated Depreciation
1,146 1,229 1,270 1,315 1,399 1,447 1,494 1,580 1,624 1,673 1,758
Total Noncurrent Assets
4,766 4,783 4,817 3,591 3,576 3,575 3,540 3,496 3,526 3,528 3,478
Goodwill
2,192 2,194 2,197 976 980 980 980 980 980 980 980
Intangible Assets
1,025 1,025 1,025 1,025 1,025 1,025 1,025 1,025 1,025 1,025 1,025
Other Noncurrent Operating Assets
1,549 1,564 1,596 1,590 1,571 1,570 1,535 1,491 1,521 1,523 1,473
Total Liabilities & Shareholders' Equity
6,577 6,572 6,662 5,427 5,259 5,277 5,211 5,121 5,153 5,205 5,085
Total Liabilities
4,249 4,171 4,247 4,234 4,097 4,145 4,089 4,014 4,014 4,048 3,929
Total Current Liabilities
1,057 997 1,075 1,115 1,069 1,118 1,114 1,083 1,059 1,103 1,130
Short-Term Debt
23 5.91 5.08 5.08 3.68 5.10 5.29 5.37 5.46 5.10 13
Accounts Payable
385 394 478 487 465 474 448 474 423 430 481
Accrued Expenses
220 207 220 216 198 197 191 190 192 210 216
Current Employee Benefit Liabilities
125 109 91 101 95 135 129 109 131 112 108
Other Current Liabilities
305 282 281 306 308 307 340 305 307 347 312
Total Noncurrent Liabilities
3,192 3,174 3,173 3,119 3,027 3,027 2,975 2,930 2,956 2,944 2,799
Long-Term Debt
1,631 1,612 1,589 1,575 1,574 1,576 1,577 1,579 1,581 1,582 1,464
Noncurrent Deferred & Payable Income Tax Liabilities
298 298 294 271 241 220 211 208 221 221 235
Other Noncurrent Operating Liabilities
1,262 1,265 1,290 1,273 1,212 1,232 1,187 1,143 1,154 1,141 1,100
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,328 2,401 2,415 1,193 1,162 1,131 1,123 1,107 1,139 1,158 1,155
Total Preferred & Common Equity
2,328 2,401 2,415 1,193 1,162 1,131 1,123 1,107 1,139 1,158 1,155
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
2,328 2,401 2,415 1,193 1,162 1,131 1,123 1,107 1,139 1,158 1,155
Common Stock
2,132 2,174 2,197 2,213 2,247 2,261 2,271 2,289 2,298 2,305 2,319
Retained Earnings
200 231 216 -1,025 -1,094 -1,119 -1,135 -1,161 -1,147 -1,137 -1,155
Accumulated Other Comprehensive Income / (Loss)
-4.52 -3.59 1.79 4.54 9.01 -11 -13 -20 -12 -9.76 -8.72

Annual Metrics And Ratios for Petco Health and Wellness

This table displays calculated financial ratios and metrics derived from Petco Health and Wellness' official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
DEI Shares Outstanding
- - - - - - 319,034,903.00
DEI Adjusted Shares Outstanding
- - - - - - 319,034,903.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - 0.03
Growth Metrics
- - - - - - -
Profitability Metrics
- - - - - - -
Net Operating Profit after Tax (NOPAT)
77 136 196 155 -826 4.94 84
Return On Investment Capital (ROIC_SIMPLE)
- - - 3.83% -29.76% 0.18% 3.17%
Earnings before Interest and Taxes (EBIT)
111 194 301 213 -1,176 12 120
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
308 393 479 412 -970 216 322
Valuation Ratios
- - - - - - -
Leverage & Solvency
- - - - - - -
Liquidity Ratios
- - - - - - -
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -3,456 1,107 -995 353 125 215
Efficiency Ratios
- - - - - - -
Capital & Investment Metrics
- - - - - - -
Invested Capital
0.00 3,592 2,681 3,831 2,651 2,531 2,401
Increase / (Decrease) in Invested Capital
0.00 3,592 -911 1,149 -1,180 -120 -131
Book Value per Share
$0.00 $9.82 $7.52 $7.84 $3.87 $3.55 $3.65
Tangible Book Value per Share
$0.00 ($5.39) $0.30 ($2.76) ($2.68) ($2.84) ($2.64)
Total Capital
0.00 3,704 3,896 4,033 2,777 2,697 2,657
Total Debt
0.00 1,648 1,640 1,651 1,592 1,583 1,493
Total Long-Term Debt
0.00 1,646 1,640 1,628 1,576 1,578 1,489
Net Debt
0.00 1,537 1,429 1,449 1,467 1,418 1,236
Capital Expenditures (CapEx)
157 156 239 276 226 127 125
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -207 -194 -184 -271 -326 -366
Debt-free Net Working Capital (DFNWC)
0.00 -96 18 18 -145 -160 -110
Net Working Capital (NWC)
0.00 -98 18 -5.26 -161 -166 -114
Net Nonoperating Expense (NNE)
181 168 36 65 454 107 75
Net Nonoperating Obligations (NNO)
0.00 1,537 426 1,449 1,467 1,418 1,236
Total Depreciation and Amortization (D&A)
197 199 178 199 206 205 202
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.62 $0.34 ($4.78) ($0.37) $0.03
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 264.26M 265.52M 267.55M 273.41M 279.56M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.62 $0.34 ($4.78) ($0.37) $0.03
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 265.34M 265.95M 267.55M 273.41M 286.15M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 303.03M 304.55M 307.37M 315.13M 322.15M
Normalized Net Operating Profit after Tax (NOPAT)
91 136 196 155 30 4.94 84
Debt Service Ratios
- - - - - - -
Payout Ratios
- - - - - - -

Quarterly Metrics And Ratios for Petco Health and Wellness

This table displays calculated financial ratios and metrics derived from Petco Health and Wellness' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 10/28/2023 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025 1/31/2026 5/2/2026
DEI Shares Outstanding
- - - - - - - - - 319,034,903.00 322,146,426.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 319,034,903.00 322,146,426.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - -0.01 -0.05
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-0.47% 6.12% -1.72% -0.46% 1.16% -7.31% -2.34% -2.31% -3.11% - 0.22%
EBITDA Growth
-1,305.47% -57.32% -61.25% -29.46% 105.40% 26.58% 113.57% 75.19% 25.87% - 11.26%
EBIT Growth
-2,633.41% -99.78% -163.89% -90.45% 101.01% 9,772.29% 184.12% 1,643.19% 134.66% - 50.53%
NOPAT Growth
-2,326.67% -99.77% -160.77% -89.73% 100.32% 10,374.70% 197.48% 2,215.58% 634.12% - 50.53%
Net Income Growth
-6,330.61% -168.97% -2,356.82% -69.95% 98.66% 38.71% 74.91% 156.29% 155.96% - -29.89%
EPS Growth
-6,714.29% -169.23% -1,600.00% -80.00% 98.70% 44.44% 76.47% 155.56% 150.00% - -25.00%
Operating Cash Flow Growth
-68.52% -65.56% -122.35% -28.20% -39.81% 104.14% -83.67% 23.82% 334.71% - -100.39%
Free Cash Flow Firm Growth
356.29% 207.38% 1,373.89% 11.07% -85.92% -88.81% -91.43% -92.97% 113.56% - 6.20%
Invested Capital Growth
-31.31% -30.79% -31.51% -32.61% -1.70% -4.52% -3.47% -1.86% -3.13% - -3.62%
Revenue Q/Q Growth
-2.39% 12.07% -8.68% -0.35% -0.81% 2.69% -3.78% -0.33% -1.62% - -1.21%
EBITDA Q/Q Growth
-1,658.88% 104.55% -41.57% 70.30% 19.43% 6.52% -1.42% 39.70% -14.20% - -7.81%
EBIT Q/Q Growth
-4,869.36% 100.01% -11,815.06% 112.69% 404.13% 31.72% -0.18% 162.99% -32.14% - -22.70%
NOPAT Q/Q Growth
-5,225.99% 100.01% -10,209.64% 114.71% 61.14% 337.21% -5.92% 249.34% -48.91% - 111.17%
Net Income Q/Q Growth
-8,397.45% 98.18% -105.90% 46.60% 32.83% 17.01% 15.73% 219.82% -33.22% - -488.19%
EPS Q/Q Growth
-9,160.00% 98.06% -88.89% 47.06% 33.33% 16.67% 20.00% 225.00% -40.00% - -400.00%
Operating Cash Flow Q/Q Growth
-64.36% 36.57% -117.89% 924.46% -70.13% 363.20% -116.10% 655.79% 4.89% - -120.17%
Free Cash Flow Firm Q/Q Growth
-70.06% 249.42% 2.37% 3.72% -96.20% 177.79% -21.61% -14.90% 15.24% - 563.29%
Invested Capital Q/Q Growth
-31.35% 0.69% -0.02% -2.50% 0.14% -2.20% 1.08% -0.87% -1.15% - 2.72%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
36.81% 36.21% 37.84% 38.11% 38.09% 37.96% 38.17% 39.32% 38.86% - 38.38%
EBITDA Margin
-78.98% 3.21% 2.05% 3.50% 4.22% 4.38% 4.48% 6.29% 5.48% - 5.01%
Operating Margin
-82.46% 0.01% -1.10% 0.16% 0.26% 1.12% 1.10% 2.89% 1.99% - 1.65%
EBIT Margin
-82.46% 0.01% -1.27% 0.16% 0.82% 1.06% 1.10% 2.89% 1.99% - 1.65%
Profit (Net Income) Margin
-83.07% -1.35% -3.04% -1.63% -1.10% -0.89% -0.78% 0.94% 0.64% - -1.01%
Tax Burden Percent
97.91% 57.64% 83.23% 73.74% 75.76% 84.14% 73.92% 131.39% -513.48% - 81.86%
Interest Burden Percent
102.89% -23,593.98% 287.17% -1,364.06% -176.89% -100.35% -96.44% 24.72% -6.22% - -75.13%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 7.02% 0.00% - 0.00%
Return on Invested Capital (ROIC)
-109.96% 0.01% -1.47% 0.22% 0.44% 1.85% 1.79% 6.35% 3.29% - 2.73%
ROIC Less NNEP Spread (ROIC-NNEP)
-135.67% -1.54% -3.82% -1.63% -0.90% 0.05% 0.22% 4.52% 2.50% - 0.39%
Return on Net Nonoperating Assets (RNNOA)
-113.50% -1.26% -3.17% -1.32% -1.13% 0.06% 0.28% 5.67% 3.08% - 0.48%
Return on Equity (ROE)
-223.46% -1.25% -4.64% -1.10% -0.69% 1.91% 2.07% 12.02% 6.37% - 3.21%
Cash Return on Invested Capital (CROIC)
13.24% 10.90% 11.10% 11.79% 1.44% 4.82% 4.61% 4.09% 6.09% - 7.28%
Operating Return on Assets (OROA)
-84.61% 0.01% -1.34% 0.17% 0.97% 1.22% 1.28% 3.35% 2.30% - 1.92%
Return on Assets (ROA)
-85.24% -1.41% -3.20% -1.70% -1.29% -1.03% -0.91% 1.09% 0.73% - -1.18%
Return on Common Equity (ROCE)
-223.46% -1.25% -4.64% -1.10% -0.69% 1.91% 2.07% 12.02% 6.37% - 3.21%
Return on Equity Simple (ROE_SIMPLE)
-102.69% 0.00% -113.98% -117.99% -9.85% 0.00% -6.05% 0.00% 0.00% - 0.00%
Net Operating Profit after Tax (NOPAT)
-862 0.12 -12 1.73 2.78 12 11 40 20 -154 17
NOPAT Margin
-57.72% 0.01% -0.77% 0.11% 0.18% 0.78% 0.77% 2.69% 1.40% - 1.15%
Net Nonoperating Expense Percent (NNEP)
25.71% 1.56% 2.35% 1.85% 1.34% 1.80% 1.57% 1.83% 0.79% - 2.34%
Return On Investment Capital (ROIC_SIMPLE)
- 0.00% - - - 0.45% 0.43% 1.47% 0.74% -5.81% 0.65%
Cost of Revenue to Revenue
63.19% 63.79% 62.16% 61.89% 61.91% 62.04% 61.83% 60.68% 61.14% - 61.62%
SG&A Expenses to Revenue
37.45% 36.20% 38.94% 37.95% 37.83% 36.84% 37.07% 36.43% 36.86% - 36.73%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Operating Expenses to Revenue
119.27% 36.20% 38.94% 37.95% 37.83% 36.84% 37.07% 36.43% 36.86% - 36.73%
Earnings before Interest and Taxes (EBIT)
-1,232 0.17 -19 2.47 12 16 16 43 29 32 25
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-1,180 54 31 53 64 68 67 94 80 81 75
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.84 0.64 0.41 0.80 1.25 0.96 0.87 0.81 0.87 - 0.80
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Price to Revenue (P/Rev)
0.16 0.12 0.08 0.14 0.22 0.18 0.16 0.15 0.17 - 0.16
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 166.24
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.60%
Enterprise Value to Invested Capital (EV/IC)
0.93 0.84 0.74 0.91 1.11 0.98 0.94 0.92 0.94 - 0.91
Enterprise Value to Revenue (EV/Rev)
0.40 0.36 0.32 0.38 0.46 0.41 0.40 0.38 0.39 - 0.38
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 14.18 11.50 9.58 7.95 7.65 - 6.79
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 210.08 50.69 26.33 22.49 - 17.39
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 504.42 85.86 41.09 31.83 - 24.85
Enterprise Value to Operating Cash Flow (EV/OCF)
8.01 10.32 11.58 16.53 22.28 14.01 14.16 12.41 9.20 - 7.50
Enterprise Value to Free Cash Flow (EV/FCFF)
5.71 6.30 5.43 6.22 76.19 19.95 20.10 22.20 15.21 - 12.25
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.32 1.34 1.36 1.40 1.41 1.42 1.43 1.39 1.37 - 1.28
Long-Term Debt to Equity
1.32 1.33 1.35 1.39 1.40 1.42 1.43 1.39 1.37 - 1.27
Financial Leverage
0.84 0.82 0.83 0.81 1.25 1.26 1.30 1.26 1.23 - 1.22
Leverage Ratio
3.41 3.36 3.32 3.37 4.59 4.59 4.57 4.59 4.57 - 4.51
Compound Leverage Factor
3.51 -792.40 9.53 -45.92 -8.13 -4.61 -4.41 1.14 -0.28 - -3.39
Debt to Total Capital
56.98% 57.34% 57.59% 58.28% 58.49% 58.71% 58.87% 58.20% 57.82% - 56.12%
Short-Term Debt to Total Capital
0.18% 0.57% 0.13% 0.19% 0.20% 0.20% 0.20% 0.20% 0.19% - 0.50%
Long-Term Debt to Total Capital
56.80% 56.77% 57.45% 58.09% 58.29% 58.51% 58.67% 58.00% 57.64% - 55.62%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Common Equity to Total Capital
43.02% 42.66% 42.41% 41.72% 41.51% 41.29% 41.13% 41.80% 42.18% - 43.88%
Debt to EBITDA
-1.76 -1.64 -1.55 -1.52 7.82 7.31 6.29 5.43 5.14 - 4.48
Net Debt to EBITDA
-1.60 -1.51 -1.46 -1.39 7.25 6.55 5.76 4.78 4.37 - 3.97
Long-Term Debt to EBITDA
-1.75 -1.63 -1.54 -1.51 7.80 7.29 6.27 5.41 5.12 - 4.44
Debt to NOPAT
-2.05 -1.93 -1.84 -1.81 -222.22 320.81 56.33 28.06 21.40 - 16.40
Net Debt to NOPAT
-1.87 -1.78 -1.74 -1.67 -205.83 287.23 51.59 24.72 18.20 - 14.55
Long-Term Debt to NOPAT
-2.04 -1.91 -1.84 -1.81 -221.48 319.73 56.14 27.97 21.33 - 16.25
Altman Z-Score
0.24 0.97 0.91 0.97 1.06 1.00 0.99 1.00 0.99 - 0.97
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.90 0.86 0.85 0.84 0.84 0.85 0.85 0.89 0.91 - 0.85
Quick Ratio
0.17 0.15 0.12 0.16 0.14 0.18 0.16 0.21 0.25 - 0.18
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
338 1,180 1,208 1,252 48 132 104 88 102 -24 110
Operating Cash Flow to CapEx
55.08% 95.84% -25.78% 253.29% 67.33% 260.62% -56.96% 277.45% 307.18% - -81.17%
Free Cash Flow to Firm to Interest Expense
9.19 29.75 32.80 34.03 1.33 3.87 3.09 2.65 3.09 - 2.46
Operating Cash Flow to Interest Expense
0.94 1.19 -0.23 1.88 0.58 2.81 -0.46 2.58 2.74 - -0.69
Operating Cash Flow Less CapEx to Interest Expense
-0.76 -0.05 -1.12 1.14 -0.28 1.73 -1.27 1.65 1.85 - -1.55
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.03 1.04 1.05 1.04 1.17 1.16 1.17 1.16 1.15 - 1.17
Accounts Receivable Turnover
127.48 133.16 142.37 109.83 137.70 144.27 155.60 148.25 143.97 - 163.40
Inventory Turnover
5.21 5.84 5.78 5.80 5.49 5.67 5.68 5.82 5.63 - 5.72
Fixed Asset Turnover
7.61 7.72 7.83 7.88 7.96 7.93 8.20 8.35 8.51 - 8.83
Accounts Payable Turnover
8.69 9.01 9.09 8.20 8.34 7.75 8.02 8.30 8.40 - 7.66
Days Sales Outstanding (DSO)
2.86 2.74 2.56 3.32 2.65 2.53 2.35 2.46 2.54 - 2.23
Days Inventory Outstanding (DIO)
70.10 62.54 63.12 62.98 66.52 64.39 64.30 62.75 64.79 - 63.83
Days Payable Outstanding (DPO)
42.02 40.53 40.16 44.49 43.75 47.07 45.49 43.98 43.47 - 47.66
Cash Conversion Cycle (CCC)
30.95 24.75 25.52 21.80 25.41 19.85 21.16 21.23 23.86 - 18.40
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,633 2,651 2,651 2,585 2,588 2,531 2,559 2,537 2,507 2,401 2,466
Invested Capital Turnover
1.90 1.93 1.91 1.94 2.39 2.36 2.33 2.36 2.35 - 2.37
Increase / (Decrease) in Invested Capital
-1,200 -1,180 -1,219 -1,251 -45 -120 -92 -48 -81 -131 -93
Enterprise Value (EV)
2,445 2,226 1,965 2,354 2,867 2,490 2,416 2,322 2,361 - 2,238
Market Capitalization
1,005 760 476 901 1,402 1,072 964 925 1,011 - 928
Book Value per Share
$3.90 $3.87 $3.78 $3.64 $3.60 $3.55 $3.51 $3.60 $3.64 $3.65 $3.59
Tangible Book Value per Share
($2.65) ($2.68) ($2.74) ($2.81) ($2.83) ($2.84) ($2.85) ($2.73) ($2.66) ($2.64) ($2.64)
Total Capital
2,773 2,777 2,740 2,712 2,705 2,697 2,692 2,725 2,745 2,657 2,633
Total Debt
1,580 1,592 1,578 1,581 1,582 1,583 1,585 1,586 1,587 1,493 1,478
Total Long-Term Debt
1,575 1,576 1,574 1,576 1,577 1,578 1,579 1,581 1,582 1,489 1,464
Net Debt
1,440 1,467 1,488 1,453 1,465 1,418 1,451 1,397 1,350 1,236 1,311
Capital Expenditures (CapEx)
63 49 33 27 31 37 27 31 29 37 38
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-242 -271 -251 -298 -293 -326 -291 -302 -328 -366 -323
Debt-free Net Working Capital (DFNWC)
-102 -145 -162 -171 -177 -160 -158 -114 -91 -110 -156
Net Working Capital (NWC)
-107 -161 -165 -176 -182 -166 -163 -119 -96 -114 -169
Net Nonoperating Expense (NNE)
379 23 35 27 19 26 23 26 11 -152 32
Net Nonoperating Obligations (NNO)
1,440 1,467 1,488 1,453 1,465 1,418 1,451 1,397 1,350 1,236 1,311
Total Depreciation and Amortization (D&A)
52 54 51 51 51 52 51 51 51 50 50
Debt-free, Cash-free Net Working Capital to Revenue
-3.93% -4.33% -4.04% -4.80% -4.70% -5.33% -4.79% -5.00% -5.47% - -5.41%
Debt-free Net Working Capital to Revenue
-1.66% -2.33% -2.60% -2.75% -2.83% -2.62% -2.59% -1.88% -1.52% - -2.62%
Net Working Capital to Revenue
-1.74% -2.58% -2.66% -2.83% -2.92% -2.71% -2.68% -1.97% -1.60% - -2.84%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($4.63) ($0.09) ($0.17) ($0.09) ($0.06) ($0.05) ($0.04) $0.05 $0.03 ($0.01) ($0.05)
Adjusted Weighted Average Basic Shares Outstanding
267.85M 267.55M 269.77M 273.07M 274.50M 273.41M 277.55M 279.06M 280.38M 279.56M 283.68M
Adjusted Diluted Earnings per Share
($4.63) ($0.09) ($0.17) ($0.09) ($0.06) ($0.05) ($0.04) $0.05 $0.03 ($0.01) ($0.05)
Adjusted Weighted Average Diluted Shares Outstanding
267.85M 267.55M 269.77M 273.07M 274.50M 273.41M 277.55M 285.74M 288.22M 286.15M 283.68M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
306.28M 307.37M 310.78M 312.15M 313.45M 315.13M 316.78M 318.05M 319.03M 322.15M 323.36M
Normalized Net Operating Profit after Tax (NOPAT)
-6.73 0.12 -12 1.73 2.78 12 11 40 20 22 17
Normalized NOPAT Margin
-0.45% 0.01% -0.77% 0.11% 0.18% 0.78% 0.77% 2.69% 1.40% - 1.15%
Pre Tax Income Margin
-84.84% -2.34% -3.65% -2.21% -1.46% -1.06% -1.06% 0.71% -0.12% - -1.24%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-33.54 0.00 -0.53 0.07 0.35 0.48 0.49 1.29 0.89 - 0.55
NOPAT to Interest Expense
-23.48 0.00 -0.32 0.05 0.08 0.36 0.34 1.20 0.62 - 0.39
EBIT Less CapEx to Interest Expense
-35.24 -1.23 -1.41 -0.68 -0.51 -0.60 -0.32 0.36 0.00 - -0.30
NOPAT Less CapEx to Interest Expense
-25.18 -1.23 -1.21 -0.70 -0.78 -0.72 -0.47 0.27 -0.27 - -0.47
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%

Financials Breakdown Chart

Key Financial Trends

Petco Health and Wellness (NASDAQ: WOOF) continues to show signs of operational improvement in the most recent quarter, but the business is still under pressure from heavy leverage, weak free cash flow, and inconsistent profitability. In Q1 2026, revenue was essentially flat year over year, margins held up, and the company posted a much smaller loss than in some prior periods. However, operating cash flow turned negative again after a strong Q4 2025, and the balance sheet still carries a large debt load relative to equity.

  • Revenue held steady year over year. Q1 2026 revenue was $1.497 billion, compared with $1.493 billion in Q1 2025, showing the top line is at least stable.
  • Gross profit remained solid. Gross profit in Q1 2026 was $574.4 million, nearly unchanged from $570.0 million a year ago, suggesting pricing and merchandise economics are not collapsing.
  • Operating income improved versus the prior year quarter. Q1 2026 operating income was $24.6 million, up from $16.4 million in Q1 2025.
  • SG&A stayed disciplined. Selling, general and administrative expense was $549.8 million in Q1 2026, slightly better than $553.6 million a year earlier, which helped margins.
  • Q4 2025 showed the company can still generate meaningful operating cash flow. Operating cash flow reached $153.5 million in that quarter, a strong result relative to recent history.
  • Quarterly cash balance improved versus a year ago. Cash and equivalents were $166.8 million at the end of Q1 2026, up from $133.3 million at the end of Q1 2025.
  • Net income remains volatile. Petco swung from a $15.1 million loss in Q1 2026 to $9.3 million of profit in Q3 2025, then back and forth across breakeven in other quarters. That inconsistency makes earnings quality hard to underwrite.
  • Depreciation and amortization remain large non-cash add-backs. This helps reported cash flow, but it also reflects a capital-intensive business with a meaningful asset base.
  • Inventory remains a large working-capital item. Inventories were $632.9 million in Q1 2026, which means execution on stock management remains important for cash generation.
  • Equity value remains thin relative to liabilities. Total common equity was $1.16 billion against total liabilities of $3.93 billion in Q1 2026, highlighting a leveraged capital structure.
  • Q1 2026 operating cash flow was negative. Cash from operations was -$31.0 million, reversing the positive trend seen in Q4 2025.
  • Free cash flow remains strained by capital spending. Petco spent $38.2 million on capex in Q1 2026, and after investing outflows the quarter ended with a net cash burn of $101.5 million.
  • Debt remains elevated. Q1 2026 long-term debt was $1.46 billion, with another $13.2 million of short-term debt, leaving the company sensitive to interest expense and refinancing risk.
  • Interest expense is still a major burden. In Q1 2026, interest expense was $44.6 million, which exceeded operating income and pushed the company back into a net loss.
  • Operating cash flow has been inconsistent over the last year. It ranged from negative $15.5 million in Q1 2025 to positive $153.5 million in Q4 2025, then back to negative in Q1 2026.
  • Historical results show significant volatility, including a major impairment hit in Q3 2023. That kind of charge underscores that the business has faced real asset and earnings pressure over time.

Bottom line: Petco’s recent quarters suggest the business is stabilizing operationally, but not yet on solid financial footing. Investors should watch for sustained positive operating cash flow, lower leverage, and continued margin discipline before calling the turnaround durable.

06/23/26 10:16 PM ETAI Generated. May Contain Errors.

Petco Health and Wellness Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Petco Health and Wellness' fiscal year ends in January. Their fiscal year 2026 ended on January 31, 2026.

Petco Health and Wellness' net income appears to be on an upward trend, with a most recent value of $9.07 million in 2025, falling from -$103.98 million in 2019. The previous period was -$101.82 million in 2024. See where experts think Petco Health and Wellness is headed by visiting Petco Health and Wellness' forecast page.

Petco Health and Wellness' total operating income in 2025 was $120.43 million, based on the following breakdown:
  • Total Gross Profit: $2.31 billion
  • Total Operating Expenses: $2.18 billion

Over the last 6 years, Petco Health and Wellness' total revenue changed from $4.43 billion in 2019 to $5.96 billion in 2025, a change of 34.4%.

Petco Health and Wellness' total liabilities were at $4.01 billion at the end of 2025, a 1.8% decrease from 2024, and a 0.3% decrease since 2020.

In the past 5 years, Petco Health and Wellness' cash and equivalents has ranged from $111.40 million in 2020 to $256.74 million in 2025, and is currently $256.74 million as of their latest financial filing in 2025.

Over the last 6 years, Petco Health and Wellness' book value per share changed from 0.00 in 2019 to 3.65 in 2025, a change of 364.9%.



Financial statements for NASDAQ:WOOF last updated on 6/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners